- Home
- EHC
EHC
Encompass Health Corporation
as 04-03-2025 4:00pm EST
| Founded: | 1983 | Country: | United States |
| Employees: | N/A | City: | BIRMINGHAM |
| Market Cap: | N/A | IPO Year: | 1986 |
| Target Price: | $107.38 | AVG Volume (30 days): | 711.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 8 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 4.46 | EPS Growth: | 28.32 |
| 52 Week Low/High: | $78.53 - $104.55 | Next Earning Date: | 04-23-2025 |
| Revenue: | $5,373,200,000 | Revenue Growth: | 11.91% |
| Revenue Growth (this year): | 10.1% | Revenue Growth (next year): | 8.67% |
Stock Insider Trading Activity of Encompass Health Corporation (EHC)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Price Andrew L | EHC | Chief Accounting Officer | Feb 13 '25 | Sell | $98.29 | 5,042 | $495,578.18 | 69,164 |
Latest Encompass Health Corporation News
EHC Breaking Stock News: Dive into EHC Ticker-Specific Updates for Smart Investing
Argus Research
2 days ago
EHC: What does Argus have to say about EHC?
Zacks
4 days ago
Here's Why Encompass Health (EHC) is a Strong Value Stock
StockStory
7 days ago
2 Reasons EHC is Risky and 1 Stock to Buy Instead
Zacks
10 days ago
Here's Why Encompass Health (EHC) is a Strong Momentum Stock
Simply Wall St.
13 days ago
Encompass Health Corporation's (NYSE:EHC) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Zacks
15 days ago
Encompass Health Expands Partnership With Piedmont in Georgia
Zacks
16 days ago
Here's Why Encompass Health (EHC) is a Strong Growth Stock
Hospital Management
16 days ago
Encompass Health and Piedmont open new Athens rehabilitation hospital
Compare EHC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "EHC Encompass Health Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.